Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis

• P. Lovat,
• R. Stout,
• K. Best,
• P. Sloan,
• J. Armstrong

Affiliations

P. Lovat

Newcastle University, Translation and Clinical Research Institute, Newcastle upon Tyne, United Kingdom; AMLo Biosciences Ltd, Newcastle upon Tyne, United Kingdom

R. Stout

Newcastle University, Translation and Clinical Research Institute, Newcastle upon Tyne, United Kingdom; AMLo Biosciences Ltd, Newcastle upon Tyne, United Kingdom

K. Best

Newcastle University, Translation and Clinical Research Institute, Newcastle upon Tyne, United Kingdom

P. Sloan

AMLo Biosciences Ltd, Newcastle upon Tyne, United Kingdom

J. Armstrong

AMLo Biosciences Ltd, Newcastle upon Tyne, United Kingdom; Sunderland University, Faculty of Health Sciences and Wellbeing, Sunderland, United Kingdom